| 000 | 01679cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030600.0 | ||
| 008 | 120306s2011 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.08.08.Ph.D.2011.Ib.F | ||
| 100 | 0 | _aIbrahim Elsayed Mohamed Hassan | |
| 245 | 1 | 0 |
_aFormulation and evaluation of controlled release dosage forms for a central nervous system acting drug / _cIbrahim Elsayed Mohamed Hassan ; Supervised Soad A. Yehia , Ahmed H. Elshafeey |
| 246 | 1 | 5 | _aصياغة وتقييم أشكال صيدلية منضبطة الانطلاق لعقار يعمل على الجهاز العصبى المركزى |
| 260 |
_aCairo : _bIbrahim Elsayed Mohamed Hassan , _c2011 |
||
| 300 |
_a246 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics | ||
| 520 | _aAlzeimer's disease is a chronic , progressive , neurodegenerative disorder of the brain characterized by deficits in memory and cognitive function . Donepezil is a reversible , noncompetitive cholinesterase inhibitor . Formulation and In Vitro Evaluation of Injectable Donepezil lipospheres . Donepezil HCI lipospheres were prepared using melt dispersion technique | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aDonepezil | |
| 653 | 4 | _aIn situ implant | |
| 653 | 4 | _aLipospheres | |
| 700 | 0 |
_aAhmed Hassan Elshafeey , _eSupervisor |
|
| 700 | 0 |
_aSoad Ali Yehia , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c37731 _d37731 |
||